Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Martin

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Clinics in Liver Disease|July 5, 2016
Alcoholic Liver DiseaseStanley Martin Cohen
American Journal of Therapeutics|March 19, 2002
Current immunosuppression in liver transplantationStanley Martin Cohen
The Journal of Family Practice|February 3, 2006
The liver transplant recipient: what you need to know for long-term careJosh Levitsky, Stanley Martin Cohen
Hepatitis Monthly|December 6, 2011
Prevention of hepatitis B recurrence in liver transplant patients using oral antiviral therapy without long-term hepatitis B immunoglobulinJoseph Ahn, Stanley Martin Cohen
Hepatology (Baltimore, Md.)|June 3, 2023
A standardized scoring system for conflict of interest determination and mitigation for AASLD-sponsored continuing medical education eventsStanley Martin Cohen, Joseph Ahn
Clinics in Liver Disease|November 23, 2019
Drug-Induced Liver Injury from StatinsLindsay Meurer, Stanley Martin Cohen
Gastroenterology|September 28, 2019
Dyspnea in Hepatocellular CarcinomaAl Tripathi, Raj Paspulati, Stanley Martin Cohen
The Journal of Arthroplasty|August 30, 2005
Operative risk of total hip and knee arthroplasty in cirrhotic patientsStanley Martin Cohen, Helen S Te, Josh Levitsky
The Annals of Pharmacotherapy|February 6, 2009
Use of specialty care versus standard retail pharmacies for treatment of hepatitis CStanley Martin Cohen, Mary J Kwasny, Joseph Ahn
Journal of Pharmacological Sciences|July 25, 2016
Nalfurafine hydrochloride, a selective κ opioid receptor agonist, has no reinforcing effect on intravenous self-administration in rhesus monkeysXiulu Ruan, Stanley Martin Hall, Alan David Kaye
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Clinics in Liver Disease|July 5, 2016
Alcoholic Liver DiseaseStanley Martin Cohen
American Journal of Therapeutics|March 19, 2002
Current immunosuppression in liver transplantationStanley Martin Cohen
The Journal of Family Practice|February 3, 2006
The liver transplant recipient: what you need to know for long-term careJosh Levitsky, Stanley Martin Cohen
Hepatitis Monthly|December 6, 2011
Prevention of hepatitis B recurrence in liver transplant patients using oral antiviral therapy without long-term hepatitis B immunoglobulinJoseph Ahn, Stanley Martin Cohen
Hepatology (Baltimore, Md.)|June 3, 2023
A standardized scoring system for conflict of interest determination and mitigation for AASLD-sponsored continuing medical education eventsStanley Martin Cohen, Joseph Ahn
Clinics in Liver Disease|November 23, 2019
Drug-Induced Liver Injury from StatinsLindsay Meurer, Stanley Martin Cohen
Gastroenterology|September 28, 2019
Dyspnea in Hepatocellular CarcinomaAl Tripathi, Raj Paspulati, Stanley Martin Cohen
The Journal of Arthroplasty|August 30, 2005
Operative risk of total hip and knee arthroplasty in cirrhotic patientsStanley Martin Cohen, Helen S Te, Josh Levitsky
The Annals of Pharmacotherapy|February 6, 2009
Use of specialty care versus standard retail pharmacies for treatment of hepatitis CStanley Martin Cohen, Mary J Kwasny, Joseph Ahn
Journal of Pharmacological Sciences|July 25, 2016
Nalfurafine hydrochloride, a selective κ opioid receptor agonist, has no reinforcing effect on intravenous self-administration in rhesus monkeysXiulu Ruan, Stanley Martin Hall, Alan David Kaye
Pageof 3